Published in Head Neck on May 01, 1997
Fortnightly review: oral cancer. BMJ (1999) 1.71
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer (2010) 1.42
Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg (2003) 1.28
The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer. Support Care Cancer (2007) 1.18
Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol (2008) 1.09
The effects of mindfulness-based stress reduction on objective and subjective sleep parameters in women with breast cancer: a randomized controlled trial. Psychooncology (2014) 0.95
Evaluation of parotid gland function following intensity modulated radiation therapy for head and neck cancer. Cancer Res Treat (2006) 0.87
Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck. Oral Dis (2008) 0.86
Levels of scientific evidence of the quality of life in patients treated for oral cancer. Med Oral Patol Oral Cir Bucal (2013) 0.81
Functional outcomes and quality of life after chemoradiotherapy: baseline and 3 and 6 months post-treatment. Dysphagia (2014) 0.81
Head and neck cancer pain: systematic review of prevalence and associated factors. J Oral Maxillofac Res (2012) 0.78
Long-term functional outcomes and patient perspective following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia (2012) 0.78
High-dose-rate interstitial brachytherapy in early stage oral tongue cancer - 15 year experience from a tertiary care institute. J Contemp Brachytherapy (2016) 0.77
Oral cancer malnutrition impacts weight and quality of life. Nutrients (2015) 0.77
The relationship between weight loss and health-related quality of life in persons treated for head and neck cancer. Support Care Cancer (2010) 0.76
The quality of life of patients treated for tongue cancer. Head Neck (1998) 0.75
Design of a randomized controlled double-blind crossover clinical trial to assess the effects of saliva substitutes on bovine enamel and dentin in situ. BMC Oral Health (2011) 0.75
Factors influencing quality of life in patients during radiotherapy for head and neck cancer. Arch Med Sci (2013) 0.75
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science (1997) 11.89
Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord (2000) 6.25
A classification of chronic hepatitis. Lancet (1968) 6.07
Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity (1998) 5.38
Benign solitary Schwannomas (neurilemomas). Cancer (1969) 4.74
The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature (1993) 4.26
Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science (1999) 4.20
Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol (2001) 4.09
Partners in transcription: NFAT and AP-1. Oncogene (2001) 3.83
Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature (1998) 3.71
Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol Cell (2000) 3.44
Nuclear factor of activated T cells contains Fos and Jun. Nature (1992) 3.43
Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg (1995) 3.24
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest (1998) 3.18
Transcriptional regulation of the IL-2 gene. Curr Opin Immunol (1995) 3.14
Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum (2004) 3.12
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.06
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol (1999) 2.97
GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules. J Cell Biol (1997) 2.92
An enhanced immune response in mice lacking the transcription factor NFAT1. Science (1996) 2.55
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg (2001) 2.54
NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc Natl Acad Sci U S A (1999) 2.48
Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. Mol Cell (1998) 2.44
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol (1993) 2.42
Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature (1997) 2.41
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Oncol (2000) 2.39
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31
Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. Am J Surg (1974) 2.30
Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci U S A (1995) 2.24
Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J (2000) 2.14
Analysis of the AP-1 sites in the IL-2 promoter. J Immunol (1992) 2.14
Cell-type-restricted binding of the transcription factor NFAT to a distal IL-4 enhancer in vivo. Immunity (2000) 2.13
Calcineurin: from structure to function. Curr Top Cell Regul (2000) 2.10
Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol Cell Biol (1996) 2.03
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol (1999) 2.03
CENP-F is a .ca 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization. Cell Motil Cytoskeleton (1993) 1.99
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol (2002) 1.96
Bridging the NFAT and NF-kappaB families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress. Immunity (2001) 1.94
Postsynaptically silent synapses in single neuron cultures. Neuron (1998) 1.94
Sweat gland carcinoma: a clinico-pathologic study of 83 patients. Ann Surg (1971) 1.94
Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J Exp Med (1993) 1.93
Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem (1996) 1.91
Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutr (1994) 1.90
Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys (2001) 1.89
The measurement of symptoms in children with cancer. J Pain Symptom Manage (2000) 1.85
NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. J Biol Chem (1993) 1.84
Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys (1999) 1.81
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol (2000) 1.80
Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity (2000) 1.79
The role of infection in the etiology of preterm birth. Obstet Gynecol (1988) 1.76
Meta-analysis of resting metabolic rate in formerly obese subjects. Am J Clin Nutr (1999) 1.73
Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow "focal" ablation. Circulation (2001) 1.73
The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. Int J Radiat Oncol Biol Phys (1994) 1.73
Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys (2000) 1.71
A similar DNA-binding motif in NFAT family proteins and the Rel homology region. J Biol Chem (1995) 1.70
Symptom prevalence, characteristics, and distress in AIDS outpatients. J Pain Symptom Manage (1999) 1.68
Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am J Surg (1978) 1.67
The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord (2001) 1.65
Testicular microlithiasis: what is its association with testicular cancer? Radiology (2001) 1.65
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorg Med Chem Lett (2001) 1.64
Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol (1994) 1.62
Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol Cell Biol (1996) 1.61
Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg (1986) 1.59
Cognitive functions in survivors of primary central nervous system lymphoma. Neurology (2004) 1.59
Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP). J Exp Med (1998) 1.58
Effect of sensory perception of foods on appetite and food intake: a review of studies on humans. Int J Obes Relat Metab Disord (2003) 1.57
Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol (1990) 1.57
Expression of the transcription factor NFATp in a neuronal cell line and in the murine nervous system. J Biol Chem (1994) 1.56
A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J (1994) 1.56
Proceedings: Ameloblastoma of maxilla and mandible. Cancer (1974) 1.56
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies. J Natl Cancer Inst (1991) 1.55
Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ (2004) 1.54
Oxidative stress and antioxidants in epilepsy. Clin Chim Acta (2001) 1.53
The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-alpha gene transcription. J Biol Chem (1994) 1.52
American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. J Clin Oncol (1999) 1.52
Tumors of minor salivary origin. A clinicopathologic study of 492 cases. Cancer (1973) 1.50
Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models. Int J Radiat Oncol Biol Phys (2000) 1.50
Nevus cell aggregates associated with lymph nodes: estimated frequency and clinical significance. Cancer (1977) 1.49
Estrogen and progesterone receptor content in human thyroid disease. Am J Clin Pathol (1993) 1.49
Down-regulation of IL-4 gene transcription and control of Th2 cell differentiation by a mechanism involving NFAT1. Immunity (1997) 1.49
Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg (1992) 1.48
Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import. Proc Natl Acad Sci U S A (1996) 1.47
Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates. Pain (1996) 1.46
Cervical nodal metastases of unknown origin. Am J Surg (1970) 1.46
Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer (1995) 1.45
Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells. Cell (1988) 1.45
2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol (2000) 1.43
Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. J Immunol (1993) 1.43
Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture. Am J Clin Nutr (1997) 1.43
Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. J Exp Med (1995) 1.43
Critical review of complementary therapies in haemato-oncology. Intern Med J (2006) 1.42
Factors associated with complications in microvascular reconstruction of head and neck defects. Plast Reconstr Surg (1999) 1.40
Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. Am J Surg (1995) 1.40
The undertreatment of pain in ambulatory AIDS patients. Pain (1997) 1.40
T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg (1975) 1.40
Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery (1997) 1.40